Data / Form D filings / ImmVue Therapeutics Inc.
ImmVue Therapeutics Inc.: Form D filings
ImmVue Therapeutics Inc., a biotechnology company in Toronto, Ontario, Canada, filed 2 Form D notices with the SEC in 2024. The latest, on April 18, 2024, reports $529,300 sold of a $529,300 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 252 RUSSELL HILL RD, Toronto, Ontario, Canada, M4V 2
- Phone
- (416) 834-5537
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2009514
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 18, 2024 | Amendment | $529,300 | $529,300 | 3 | Jan 31, 2024 | sec.gov | |
| Mar 19, 2024 | New notice | $1,154,050 | $154,050 | $1,000,000 | 2 | Jan 31, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Moon | Executive Officer, Director | |
| Jayan John Nagendran | Director | |
| Joon-Hyung John Kim | Director | |
| Sandy Der | Executive Officer, Director |
Every Form D from the week of Apr 15, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ImmVue Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.